Maddamsetti, R. et al. Duplicated antibiotic resistance genes reveal ongoing selection and horizontal gene transfer in bacteria. Nat. Commun. 15, 1449 (2024).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu, G. & Stokes, J. M. A brief guide to machine learning for antibiotic discovery. Curr. Opin. Microbiol. 69, 102190 (2022).

Article  PubMed  CAS  Google Scholar 

Naghavi, M. et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet 404, 1199–1226 (2024).

Article  Google Scholar 

O’Neill, J. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. Review on Antimicrobial Resistance (HM Government & Wellcome Trust, 2014).

Hawkey, P. M. et al. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party. J. Antimicrob. Chemother. 73, iii2–iii78 (2018).

Article  PubMed  CAS  Google Scholar 

Tzouvelekis, L. S., Markogiannakis, A., Psichogiou, M., Tassios, P. T. & Daikos, G. L. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin. Microbiol. Rev. 25, 682–707 (2012).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ordooei Javan, A., Shokouhi, S. & Sahraei, Z. A review on colistin nephrotoxicity. Eur. J. Clin. Pharmacol. 71, 801–810 (2015).

Article  PubMed  CAS  Google Scholar 

Li, J. et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6, 589–601 (2006).

Article  PubMed  CAS  Google Scholar 

Nitzan, O., Elias, M., Peretz, A. & Saliba, W. Role of antibiotics for treatment of inflammatory bowel disease. World J. Gastroenterol. 22, 1078–1087 (2016).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zangara, M. T., Darwish, L. & Coombes, B. K. Characterizing the pathogenic potential of Crohn’s disease-associated adherent-invasive Escherichia coli. EcoSal Plus 11, eesp-0018-2022 (2023).

Levy, M., Kolodziejczyk, A. A., Thaiss, C. A. & Elinav, E. Dysbiosis and the immune system. Nat. Rev. Immunol. 17, 219–232 (2017).

Article  PubMed  CAS  Google Scholar 

Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 15, 382–392 (2014).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Baumgart, M. et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn’s disease involving the ileum. ISME J. 1, 403–418 (2007).

Article  PubMed  CAS  Google Scholar 

Morgan, X. C. et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, R79 (2012).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tang, X. et al. Structural basis for bacterial lipoprotein relocation by the transporter LolCDE. Nat. Struct. Mol. Biol. 28, 347–355 (2021).

Article  PubMed  CAS  Google Scholar 

Baron, A. P. et al. Probing the catalytic functions of Bub1 kinase using the small molecule inhibitors BAY-320 and BAY-524. eLife 5, e12187 (2016).

King, A. M. et al. Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance. Nature 510, 503–506 (2014).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ricci, D. P. & Silhavy, T. J. The Bam machine: a molecular cooper. Biochim. Biophys. Acta 1818, 1067–1084 (2012).

Article  PubMed  CAS  Google Scholar 

Blair, J. M. & Piddock, L. J. Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update. Curr. Opin. Microbiol 12, 512–519 (2009).

Article  PubMed  CAS  Google Scholar 

Cox, G. et al. A common platform for antibiotic dereplication and adjuvant discovery. Cell Chem. Biol. 24, 98–109 (2017).

Article  PubMed  CAS  Google Scholar 

French, S. et al. Potentiation of antibiotics against Gram-negative bacteria by polymyxin B analogue SPR741 from unique perturbation of the outer membrane. ACS Infect. Dis. 6, 1405–1412 (2020).

Article  PubMed  CAS  Google Scholar 

Macnair, C. R. & Brown, E. D. Outer membrane disruption overcomes intrinsic, acquired, and spontaneous antibiotic resistance. mBio 11, e01615-20 (2020).

Zurawski, D. V. et al. SPR741, an antibiotic adjuvant, potentiates the in vitro and in vivo activity of rifampin against clinically relevant extensively drug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 61, e01239-17 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Eckburg, P. B. et al. Safety, tolerability, pharmacokinetics, and drug interaction potential of SPR741, an intravenous potentiator, after single and multiple ascending doses and when combined with β-lactam antibiotics in healthy subjects. Antimicrob. Agents Chemother. 63, e00892-19 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Gill, S. R. et al. Metagenomic analysis of the human distal gut microbiome. Science 312, 1355–1359 (2006).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu, G. et al. Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nat. Chem. Biol. 19, 1342–1350 (2023).

Article  PubMed  CAS  Google Scholar 

Breidenstein, E. B. M. et al. SMT-738: a novel small-molecule inhibitor of bacterial lipoprotein transport targeting Enterobacteriaceae. Antimicrob. Agents Chemother. 68, e00695-23 (2024).

Article  PubMed  CAS  Google Scholar 

Nayar, A. S. et al. Novel antibacterial targets and compounds revealed by a high-throughput cell wall reporter assay. J. Bacteriol. 197, 1726–1734 (2015).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lorenz, C., Dougherty, T. J. & Lory, S. Correct sorting of lipoproteins into the inner and outer membranes of Pseudomonas aeruginosa by the Escherichia coli LolCDE transport system. mBio 10, e00194-19 (2019).

Nickerson, N. N. et al. A novel inhibitor of the LolCDE ABC transporter essential for lipoprotein trafficking in Gram-negative bacteria. Antimicrob. Agents Chemother. 62, e02151-17 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Muñoz, K. A. et al. A Gram-negative-selective antibiotic that spares the gut microbiome. Nature 630, 429–436 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Corso, G., Stärk, H., Jing, B., Barzilay, R. & Jaakkola, T. DiffDock: diffusion steps, twists, and turns for molecular docking. Preprint at https://arxiv.org/abs/2210.01776 (2022).

Corso, G. et al. Deep confident steps to new pockets: strategies for docking generalization. Preprint at https://arxiv.org/abs/2402.18396 (2024).

Fan, J., Fu, A. & Zhang, L. Progress in molecular docking. Quant. Biol. 7, 83–89 (2019).

Article  CAS  Google Scholar 

Bender, B. J. et al. A practical guide to large-scale docking. Nat. Protoc. 16, 4799–4832 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bonev, B., Hooper, J. & Parisot, J. Principles of assessing bacterial susceptibility to antibiotics using the agar diffusion method. J. Antimicrob. Chemother. 61, 1295–1301 (2008).

Article  PubMed  CAS  Google Scholar 

Tokuda, H. & Matsuyama, S. I. Sorting of lipoproteins to the outer membrane in E. coli. Biochim. Biophys. Acta 1693, 5–13 (2004).